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Abstract 
Excessive production of reactive oxygen species (ROS) contributes to progression of 
atherosclerosis, at least in part by causing endothelial dysfunction and inflammatory 
activation. The class III histone deacetylase SIRT1 has been implicated in extension of 
lifespan. In the vasculature, SIRT1 gain-of-function using SIRT1 overexpression or 
activation has been shown to improve endothelial function in mice and rats via 
stimulation of endothelial nitric oxide (NO) synthase (eNOS). However, the effects of 
SIRT1 loss-of-function on the endothelium in atherosclerosis remain to be 
characterized. Thus, we have investigated the endothelial effects of decreased 
endogenous SIRT1 in hypercholesterolemic ApoE-/- mice. We observed no difference in 
endothelial relaxation and eNOS (Ser1177) phosphorylation between 20-week old male 
atherosclerotic ApoE-/- SIRT1+/- and ApoE-/- SIRT1+/+ mice. However, SIRT1 prevented 
endothelial superoxide production, inhibited NF-κB signaling, and diminished 
expression of adhesion molecules. Treatment of young hypercholesterolemic ApoE-/- 
SIRT1+/- mice with lipopolysaccharide to boost NF-κB signaling led to a more 
pronounced endothelial expression of ICAM-1 and VCAM-1 as compared to ApoE-/- 
SIRT1+/+ mice. In conclusion, endogenous SIRT1 diminishes endothelial activation in 
ApoE-/- mice, but does not affect endothelium-dependent vasodilatation. 
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Introduction 
Inflammation plays a key role in the development and progression of atherosclerosis. In early 
stages of the disease, endothelial cells get activated by circulating proinflammatory molecules 
such as cytokines (e.g. TNFα) or modified lipoproteins (e.g. oxidized LDL). Once activated, 
these cells express chemokines, cytokines, and adhesion molecules, which attract and recruit 
inflammatory cells such as macrophages and T cells 1, 2. Hypertension, hypercholesterolemia, 
diabetes, and aging, which may all be associated with an excessive production of reactive 
oxygen species (ROS) and oxidant stress, may contribute to atherosclerosis by affecting 
endothelial function and inducing sustained endothelial activation 2-5. 
The NAD-dependent class III histone deacetylase Sir2 was found to increase lifespan in yeast 
6. Its mammalian orthologue SIRT1 senses caloric restriction, improves insulin secretion in 
pancreatic beta cells, and reduces accumulation of fatty acids in white adipose tissue 7-9. 
Various other SIRT1 targets have been identified and characterized in recent years, including 
PGC-1α, NF-κB and LXR 10-13. NF-κB is of special interest in endothelial cells, since it 
drives the expression of important adhesion molecules, such as vascular cell adhesion 
molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1), which recruit blood 
monocytes to atherosclerotic lesions 14-16. 
Endogenous SIRT1 has been shown to decrease macrophage foam cell formation and 
atherogenesis in hypercholesterolemic ApoE-/- SIRT1+/- mice 17. In non-atherosclerotic aortae 
of rats, dominant-negative SIRT1 transfection impairs endothelial function via eNOS 
inhibition ex vivo 18, and endothelial overexpression of human SIRT1 diminishes 
atherogenesis in ApoE-/- mice and improves vascular function 19. In addition, activation of 
SIRT1 prevents hyperglycemia-induced vascular cell senescence in mice with diabetes, 
thereby protecting from vascular dysfunction 20. Nevertheless, the impact of a SIRT1 
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haploinsufficiency on endothelium-dependent vasomotion and endothelial cell activation in 
atherosclerotic mice remains to be determined. 
In the present study, we therefore investigated the effects of a single SIRT1 allele on aortic 
relaxation and endothelial activation in 20-week-old atherosclerotic ApoE-/- SIRT1+/+ and 
ApoE-/- SIRT1+/- mice. 
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Results 
Endogenous SIRT1 does not alter endothelial function in ApoE-/- mice 
Overexpression of human SIRT1 in mouse endothelial cells has been shown to diminish 
atherogenesis in ApoE-/- mice.19 However, the underlying mechanisms remain to be further 
characterized. To investigate the effect of endogenous SIRT1 on endothelium-dependent 
vasodilatation and endothelial inflammatory activation, we assessed endothelium-dependent 
function and inflammatory pathways in aortic rings from 20-week-old atherosclerotic ApoE-/- 
SIRT1+/+ or ApoE-/- SIRT1+/- mice. Interestingly, the acetylcholine-mediated relaxation of 
aortic rings after precontraction with norepinephrine did not differ between ApoE-/- SIRT1+/+ 
and the haploinsufficient ApoE-/- SIRT1+/- mice (Figure 1A). Vasoconstriction with 
norepinephrine and endothelium-independent vasodilatation with sodium nitroprusside were 
normal (Figure 1B, C). eNOS-derived NO plays an important role in vascular relaxation, and 
eNOS activity is mainly regulated by Akt-dependent Ser1177 phosphorylation 21. We observed 
no difference in the Ser1177 phosphorylation status (Figure 1D). Our data indicate that 
endogenous SIRT1 in atherosclerotic ApoE-/- mice does not affect endothelial function. 
Silencing of SIRT1 enhances production of endothelial superoxide 
Common risk factors predisposing to atherosclerosis, such as hypercholesterolemia or aging, 
are associated with oxidant stress at least in part due to an increased production of ROS 22. 
We measured ROS production in human aortic endothelial cells (HAECs) treated with either 
scrambled- or SIRT1-siRNA. SIRT1 silencing elevated endothelial ROS levels upon TNFα 
stimulation, whereas under basal conditions there was no effect of SIRT1 silencing was 
observed (Figure 2).  
Enhanced expression of adhesion molecules in ApoE-/- SIRT1+/- plaques 
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Accumulating evidence suggests that chronic production of ROS may favor atherogenesis by 
inducing sustained endothelial inflammatory activation 2, 5. Expression of endothelial 
adhesion molecules play an important role in atherogenesis by promoting monocyte-derived 
macrophage recruitment and accumulation in the arterial intima 16. Interestingly, expression 
of ICAM-1 and VCAM-1 was increased in atherosclerotic plaques of ApoE-/- SIRT1+/- 
compared with ApoE-/- SIRT1+/+ mice (Figure 3). These findings show that SIRT1 prevents 
adhesion molecule expression, an important step in endothelial cell activation. 
SIRT1 regulates the expression of endothelial adhesion molecules via suppression of 
NF-κB signaling in vitro 
NF-κB plays a central role in inflammatory processes and its signaling pathway is inhibited 
by SIRT1 via deacetylation 12, 23. NF-κB induces expression of adhesion molecules and 
inflammatory cytokines, and endothelial-specific inhibition of the NF-κB pathway protects 
mice from atherosclerosis 24. SIRT1 has been shown to deacetylate the lysine residue K310 of 
RelA/p65 in human epithelial lung cells 12. To test whether RelA/p65 signaling is suppressed 
by SIRT1 in HAECs, we quantified DNA-bound RelA/p65 in TNFα-stimulated and 
unstimulated cells pretreated with the SIRT1 inhibitor splitomicin 25. Binding of RelA/p65 to 
naked DNA was enhanced upon treatment with the SIRT1 inhibitor splitomicin after TNFα 
stimulation (Figure 4A). To evaluate, if SIRT1 is also deacetylating K310 of RelA/p65 in 
HAECs, as previously reported for HEK 293T cells 12, we stimulated SIRT1- or scrambled-
siRNA-treated HAECs with TNFα and performed p65 immunoprecipitations. K310-p65 was 
increased in SIRT1-siRNA-treated HAECs (Figure 4B). To further test if suppression of NF-
κB signaling also affects the expression of adhesion molecules, we analyzed the expression of 
VCAM-1, a known NF-κB signaling target, in more detail. SIRT1-siRNA treatment enhanced 
expression of VCAM-1 in HAECs upon TNFα stimulation (Figure 4C).  
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SIRT1 regulates the expression of inflammatory endothelial molecules in vivo 
Since SIRT1 suppresses NF-κB signaling in HAECs, we investigated whether the same 
concept holds true in mouse aortae. Binding of RelA/p65 to naked DNA was higher in 
nuclear extracts of ApoE-/- SIRT1+/- than ApoE-/- SIRT1+/+ mice (Figure 5A). Importantly, 
aortic expression of other inflammatory molecules, namely IL-1β, TNFα, and P-Selectin (P-
Sel), was also enhanced in ApoE-/- SIRT1+/- compared to ApoE-/- SIRT1+/+ mice (Figure 5B). 
The expression of these inflammatory genes is regulated by NF-κB. Lipopolysaccharides 
(LPS) induce strong activation of NF-κB signaling and the expression of target genes 26. To 
address the in vivo relevance of the NF-κB suppression by SIRT1, we examined the 
expression of two known NF-κB-dependent genes, ICAM-1 and VCAM-1, in aortae from 
young 8-week-old ApoE-/- SIRT1+/- and ApoE-/- SIRT1+/+ mice without atherosclerosis in 
descending thoracic aortae 3 hours after intraperitoneal injection of LPS. LPS induced an 
upregulation of both ICAM-1 and VCAM-1 in intimal endothelial cells of aortae from ApoE-/- 
SIRT1+/- compared with ApoE-/- SIRT1+/+ mice (Figure 5C, D). These findings indicate that 
endogenous SIRT1 is sufficient to prevent adhesion molecule expression in both human and 
mouse activated endothelial cells. 
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Discussion 
Enhanced atherogenesis in ApoE-/- SIRT1+/- mice is causally linked to increased expression of 
adhesion molecules in aortae. Indeed, we provide in vitro and in vivo evidence that underlines 
this concept by demonstrating that ApoE-/- SIRT1+/- mice exhibit increased endothelial 
expression of ICAM-1 and VCAM-1 upon LPS injection. Importantly, upregulation of these 
adhesion molecules promotes recruitment of monocytes and T cells to luminal endothelial 
cells 27. In concert with increased levels of IL-1β, TNFα, and P-Sel in the activated arterial 
wall, these molecular events are sufficient to recruit circulating leukocytes to atherosclerotic 
lesions, especially monocyte-derived macrophages and T cells. 
At the molecular level, the inhibitory effects of SIRT1 on adhesion molecule expression may 
be mediated via RelA/p65 signaling. Our data show that SIRT1 suppresses binding of 
RelA/p65 to naked DNA, therefore interfering with a crucial step in the transcriptional 
activation of NF-κB. These findings are in line with previous reports showing that SIRT1 
deacetylases RelA/p65 at the lysine residue K310 in human epithelial lung cells 12. In 
agreement with these reports, we demonstrate that this mechanism of RelA/p65 signaling 
suppression is present in HAECs.  
Surprisingly, we observe no endothelial dysfunction in ApoE-/- SIRT1+/- mice. In contrast, 
Pearson et al. showed improved endothelial function in mice kept on a diet with a very high 
resveratrol content (2400 mg/kg/food) that could be mediated by SIRT1 activation 28. 
However, such effects may also be related to activation of AMPK by resveratrol or via other 
targets of this compound 29, 30. Furthermore, adenovirus-mediated inhibition of endothelial 
SIRT1 diminishes endothelium-dependent vasodilatation in rat aortic rings and decreases 
bioavailable NO levels 18. Others reported improved relaxation in ApoE-/- mice with 
endothelial SIRT1 overexpression that were kept on a high-fat diet 19. However, in this study 
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WT aortic rings showed also marked endothelial dysfunction by relaxing only up to 50%, 
thereby casting doubts on the endothelial integrity of the preparations 19. In contrast, we 
observed no change in endothelial function or aortic eNOS activity between 
hypercholesterolemic ApoE-/- SIRT1+/- and ApoE-/- SIRT1+/+ mice, suggesting that the 
endothelial-protective effects of SIRT1 include factors other than eNOS-dependent NO 
production. Indeed, we detected a profound increase in ROS-production after silencing of 
SIRT1 in TNFalpha-stimulated endothelial cells, indicating that endogenous SIRT1 inhibits 
agonist-induced ROS production in endothelial cells. Of note, an excessive production of 
ROS has been implicated in endothelial inflammatory activation and the pathogenesis of 
atherosclerosis 31. Therefore, inhibition of excessive endothelial ROS production likely 
represents an important endothelial-protective action of endogenous SIRT1. 
Taken together, our results show that SIRT1 does not influence endothelium-dependent 
vascular function in ApoE-/- mice, but it prevents superoxide production in endothelial cells 
and reduces the expression of inflammatory adhesion molecules by suppressing NF-κB 
signaling. Although the specificity of available SIRT1 activators has been questioned recently 
32, it is likely that SIRT1 activators may prevent atherosclerosis and other inflammatory 
diseases by hindering pro-oxidative and inflammatory processes. 
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Materials and Methods 
Animals. ApoE-/- SIRT1+/- and ApoE-/- SIRT1+/+ mice were described previously 17. Male 
mice were fed a high-cholesterol diet (1.25% total cholesterol, Research Diets) for 12 weeks 
starting at the age of 8 weeks. All animal procedures were approved by the local animal 
committee and performed in accordance with our institutional guidelines. 
Cell culture. Human aortic endothelial cells (HAEC, Cambrex Bio Science) were treated 
with 100 µM splitomicin (Sigma-Aldrich) to perform analysis of NF-κB binding to DNA. 
HAEC were stimulated for 30 minutes with 10 ng/ml human TNFα (R&D Systems). 
siRNA transfection. Transient transfection siRNA into HAEC were done with lipofectamin 
lipofectamin RNAi MAX (Invitrogen). The oligos used for SIRT1-siRNA have been 
described previously 9. 
Immunohistochemistry and immunofluorescence. Serial cryosections from the aortic sinus 
were stained with rabbit anti-von Willebrand Factor (Dako), rat anti-CD31, rat anti-VCAM-1 
(BD Biosciences), rat anti-ICAM-1 (Serotec). Fluorescence was analyzed on a Leica TCS 
SP2 confocal microscope and means were taken from n=6 different mice evaluating 6 serial 
cryosections/tissue from each mouse. 
RNA and protein analysis. Total RNA isolated from proximal aortae and HAEC was 
extracted with TRIZOL (Invitrogen), reverse transcribed, and the cDNA quantified by SYBR 
green qPCR using specific primers. For protein analysis, aortic tissue lysates were blotted and 
incubated with rabbit anti-SIRT1, rabbit anti-eNOS (Santa Cruz Biotechnology), and rabbit 
anti-Phospho-eNOS (Ser1177) (Cell Signaling Technology). 
Endothelial function. Aortic rings (2–3 mm long) were connected to an isometric force 
transducer (MultiMyograph), suspended in a 95% O2/5% CO2 aerated organ chamber filled 
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with KREBS buffer (118 mM NaCl, 4.7 mM KCl, 1.2 mM MgCl2, 1.2 mM NaH2PO4, 1.2 
mM Na2SO4, 2.5 mM CaCl2, 25 mM NaHCO3, 10 mM glucose, pH to 7.4). Concentration-
dependent contractions were established by using norepinephrine (10−9 to 10−4 mol/liter; 
Sigma–Aldrich).  Concentration–response curves were obtained in a cumulative fashion. 8 
rings cut from the same artery were studied in parallel. Responses to acetylcholine (10−9 to 
10−6 mol/liter; Sigma–Aldrich) were obtained during submaximal contraction to 
norepinephrine. The NO donor sodium nitroprusside (10−10 to 10−5 mol/liter; Sigma–Aldrich) 
was added to test endothelium-independent relaxations. 
LPS assay. 6 8-week-old ApoE-/- SIRT1+/- and ApoE-/- SIRT1+/+ mice kept on standard diet 
were used for this assay. At this age and under normal diet, ApoE-/- mice do not exhibit 
plaques in their thoraco-abdominal aortae. Mice were injected i.p. with 100 µg of LPS 
(Sigma) in PBS, sacrificed 3 hours post injection and thoraco-abdominal aortae embedded in 
OCT. Cryosections (5 µm) were cut and stained for ICAM-1 or VCAM-1. Relative 
expression is given as the ratio of ICAM-1 or VCAM-1 staining area to von Willebrand 
Factor (vWF) staining area, respectively. Quantification of fluorescence was done with 
analySIS (Olympus) on microscopic images using identical exposure settings. 
Quantification of DNA-bound RelA/p65. HAEC were pretreated with splitomicin for one 
hour and stimulated with 10 ng/ml TNFα for 30 minutes. Nuclear extracts of aortic tissue 
samples were obtained with the Nuclear Extract kit (ActiveMotif) using a Dounce pestle, and 
a RelA/p65 transcription factor assay was performed using the TransAM kit (ActiveMotif) 
according to the manufacturer’s instructions.  
Immunoprecipitation. HAEC were treated with 50 µM SIRT1 or scrambled siRNA over 
night, followed by 10 ng/ml TNFα stimulation for 20 minutes. Cells were then harvested and 
protein extracted in lysis buffer (20 mM HEPES, pH 7.5, 80 mM NaCl, 2.5 mM MgCl2, 
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1 mM EDTA, 100 µM Splitomicin, 0.5% NP-40, 1 mM PMFS (phenylmethylsulfonyl 
fluoride), 10 µg/ml aprotinin, and 10 µg/ml leupeptin). 1 mg whole-cell lysates were 
immunoprecipitated with rabbit anti-p65 (Santa Cruz) using Protein G agarose (Millipore). 
Immunoprecipitated samples were immunoblotted with rabbit anti-acK310-p65 (Abcam), and 
the total lysates (5% input) with rabbit anti-SIRT1 and rabbit anti-p65. 
Detection of endothelial cell superoxide production by electron spin resonance 
spectroscopy. The effect of SIRT1 on endothelial cell superoxide production was assessed in 
unstimulated and TNFα-stimulated (10 ng/ml) HAEC by ESR spectroscopy using the spin 
probe 1-hydroxy-3-methoxycarbonyl-2,2,5,5-tetramethylpyrrolidine (CMH; Noxygen). 
HAEC were incubated with 50 nM scrambled or SIRT1-siRNA with or without TNFα for 
one hour and resuspended in Krebs-Hepes buffer (pH 7.4; Noxygen) containing 
diethyldithiocarbamic acid sodium salt (5 µM, Noxygen) and deferoxamine methanesulfonate 
salt (25 µM, Noxygen). ESR spectra were recorded after addition of CMH (final 
concentration 200 µM) under stable temperature conditions using a Bruker e-scan 
spectrometer (Bruker Biospin). The ESR instrumental settings were as follows: center field, 
3495 G; field sweep width, 10.000 G; microwave frequency, 9.75 GHz; microwave power, 
19.91 mW; magnetic field modulation frequency, 86.00 kHz; modulation amplitude, 2.60 G; 
conversion time, 10.24 msec; detector time constant, 328 msec; nuber of x-scans, 10. 
Statistical analyses. Data are presented as mean ± SEM. Statistical significance of 
differences was calculated using an ANOVA with post hoc Tukey’s test or Student’s 
unpaired t test. Significance was accepted at p<0.05. 
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Figure legends 
Figure 1. ApoE-/- SIRT1+/- mice do not exhibit endothelial dysfunction. (A) No difference in 
relaxation of aortic rings preconstricted with norepinephrine to the vasodilator acetylcholine. 
% Relaxation = % of precontraction to norepinephrine. (B) Relaxation of aortic rings at 
increasing sodium nitroprusside concentrations after norepinephrine precontraction. % 
Relaxation = % of precontraction to norepinephrine. (C) Contraction of aortic rings at 
increasing norepinephrine concentrations. % Contraction = % of contraction to 80 mM KCl. 
ApoE-/- SIRT1+/- (blue line) and ApoE-/- SIRT1+/+ (black line). (D) Aortic protein levels of 
total eNOS and phospho-eNOS (Ser1177). ApoE-/- SIRT1+/- (+/- and black columns) and 
ApoE-/- SIRT1+/+ (+/+ and white columns). n=6 per genotype. 
Figure 2. Superoxide production is increased in HAECs after SIRT1-siRNA compared with 
scrambled-siRNA-treatment 1 h after TNFα stimulation. n=2. ***p<0.001. 
Figure 3. SIRT1 deletion increases adhesion molecule expression. ICAM-1 and VCAM-1 
staining and quantification in plaques from aortic sinus. Magnifications: X40. ApoE-/- 
SIRT1+/+ (+/+, n=6, white columns) and ApoE-/- SIRT1+/- (+/-, n=6, black columns). *p<0.05. 
Figure 4. SIRT1 suppresses NF-κB signaling in HAECs. (A) RelA/p65 DNA binding is 
higher in HAEC pretreated with splitomicin (Splito) compared with the untreated group (-), 
30 min after TNFα-stimulation. n=5. (B) RelA/p65 immunoprecipitation in HAECs reveals 
more acetyl-K310-RelA/p65 upon SIRT1-siRNA treatment 20 min after TNFα-stimulation 
compared to scrambled siRNA-treated cells. n=2. (C) Western blot showing SIRT1 silencing 
using siRNA (top), and VCAM-1 mRNA expression 5 h after TNFα stimulation in SIRT1-
siRNA treated HAECs (graph). n=4. *p<0.05.  
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Figure 5. SIRT1 prevents expression of endothelial adhesion molecules. (A) RelA/p65 DNA-
binding in aortic nuclear extracts from ApoE-/- SIRT1+/- (+/-, n=8, black column) is elevated in 
ApoE-/- SIRT1+/+ (+/+, n=6, white column) mice. (B) Expression levels of IL-1β, P-Selectin, 
and TNFα in aortic lysates of ApoE-/- SIRT1+/+ (white columns) and ApoE-/- SIRT1+/- (black 
columns) mice. n=8 per genotype. Enhanced expression of ICAM-1 (C) and VCAM-1 (D) is 
observed in non-atherosclerotic ApoE-/- SIRT1+/- (+/- and black columns) compared with 
ApoE-/- SIRT1+/+ (+/+ and white columns) aortae 3 h post intra-peritoneal LPS (striped 
columns) injection. n=6 per genotype. Scale: 50 µm. *p<0.05; **p< 0.01. 
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